ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tofacitinib Citrate Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-31R14566
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Tofacitinib Citrate Tablets Market Research Report 2023
BUY CHAPTERS

Global Tofacitinib Citrate Tablets Market Research Report 2025

Code: QYRE-Auto-31R14566
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Simcere Pharmaceutical Group Limited
Qilu Pharmaceutical Co. Ltd.
SPH Zhongxi Pharmaceutical Co., Ltd.
Hunan Kelun Pharmaceutical Co., Ltd.
Sinomune Pharmaceutical Co., Ltd.
Hangzhou zuyaxi MedicineCo.,Ltd.
Zhejiang Hisun Pharmaceutical Co Ltd
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Pfizer Inc
Hunan Jiudian Pharmaceutical Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.

Tofacitinib Citrate Tablets Market

The global market for Tofacitinib Citrate Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tofacitinib Citrate Tablets is an immunosuppressant, which affects the cellular hematopoietic process and cellular immune function by conducting the signals generated by the cytokine or growth factor-receptor interaction on the cell membrane.
North American market for Tofacitinib Citrate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tofacitinib Citrate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tofacitinib Citrate Tablets include Pfizer, Zhejiang Hisun Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Hunan Jiudian Pharmaceutical Co., Ltd., CSPC OUYI Pharmaceutical Co., Ltd., Chengdu Brilliant Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group Limited, Sinomune Pharmaceutical Co., Ltd., QILU Pharmaceutical Co., Ltd., Hangzhou zuyaxi MedicineCo.,Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tofacitinib Citrate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tofacitinib Citrate Tablets.
The Tofacitinib Citrate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tofacitinib Citrate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tofacitinib Citrate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tofacitinib Citrate Tablets Market Report

Report Metric Details
Report Name Tofacitinib Citrate Tablets Market
Segment by Type
  • 14 tablets/bottle
  • 28 tablets/bottle
  • Other Specifications
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Zhejiang Hisun Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Hunan Jiudian Pharmaceutical Co., Ltd., CSPC OUYI Pharmaceutical Co., Ltd., Chengdu Brilliant Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group Limited, Sinomune Pharmaceutical Co., Ltd., QILU Pharmaceutical Co., Ltd., Hangzhou zuyaxi MedicineCo.,Ltd., SPH Zhongxi Pharmaceutical Co., Ltd., Hunan Kelun Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tofacitinib Citrate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tofacitinib Citrate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Tofacitinib Citrate Tablets Market report?

Ans: The main players in the Tofacitinib Citrate Tablets Market are Pfizer, Zhejiang Hisun Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Hunan Jiudian Pharmaceutical Co., Ltd., CSPC OUYI Pharmaceutical Co., Ltd., Chengdu Brilliant Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group Limited, Sinomune Pharmaceutical Co., Ltd., QILU Pharmaceutical Co., Ltd., Hangzhou zuyaxi MedicineCo.,Ltd., SPH Zhongxi Pharmaceutical Co., Ltd., Hunan Kelun Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Tofacitinib Citrate Tablets Market report?

Ans: The Applications covered in the Tofacitinib Citrate Tablets Market report are Hospital, Retail Pharmacy, Clinic, Others

What are the Type segmentation covered in the Tofacitinib Citrate Tablets Market report?

Ans: The Types covered in the Tofacitinib Citrate Tablets Market report are 14 tablets/bottle, 28 tablets/bottle, Other Specifications

Recommended Reports

Pharmaceutical APIs

Tablet Formulations

Immunosuppressants & Therapeutics

1 Tofacitinib Citrate Tablets Market Overview
1.1 Product Definition
1.2 Tofacitinib Citrate Tablets by Type
1.2.1 Global Tofacitinib Citrate Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 14 tablets/bottle
1.2.3 28 tablets/bottle
1.2.4 Other Specifications
1.3 Tofacitinib Citrate Tablets by Application
1.3.1 Global Tofacitinib Citrate Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global Tofacitinib Citrate Tablets Market Size Estimates and Forecasts
1.4.1 Global Tofacitinib Citrate Tablets Revenue 2020-2031
1.4.2 Global Tofacitinib Citrate Tablets Sales 2020-2031
1.4.3 Global Tofacitinib Citrate Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tofacitinib Citrate Tablets Market Competition by Manufacturers
2.1 Global Tofacitinib Citrate Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tofacitinib Citrate Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tofacitinib Citrate Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tofacitinib Citrate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tofacitinib Citrate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tofacitinib Citrate Tablets, Product Type & Application
2.7 Global Key Manufacturers of Tofacitinib Citrate Tablets, Date of Enter into This Industry
2.8 Global Tofacitinib Citrate Tablets Market Competitive Situation and Trends
2.8.1 Global Tofacitinib Citrate Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tofacitinib Citrate Tablets Players Market Share by Revenue
2.8.3 Global Tofacitinib Citrate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tofacitinib Citrate Tablets Market Scenario by Region
3.1 Global Tofacitinib Citrate Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tofacitinib Citrate Tablets Sales by Region: 2020-2031
3.2.1 Global Tofacitinib Citrate Tablets Sales by Region: 2020-2025
3.2.2 Global Tofacitinib Citrate Tablets Sales by Region: 2026-2031
3.3 Global Tofacitinib Citrate Tablets Revenue by Region: 2020-2031
3.3.1 Global Tofacitinib Citrate Tablets Revenue by Region: 2020-2025
3.3.2 Global Tofacitinib Citrate Tablets Revenue by Region: 2026-2031
3.4 North America Tofacitinib Citrate Tablets Market Facts & Figures by Country
3.4.1 North America Tofacitinib Citrate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tofacitinib Citrate Tablets Sales by Country (2020-2031)
3.4.3 North America Tofacitinib Citrate Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tofacitinib Citrate Tablets Market Facts & Figures by Country
3.5.1 Europe Tofacitinib Citrate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tofacitinib Citrate Tablets Sales by Country (2020-2031)
3.5.3 Europe Tofacitinib Citrate Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tofacitinib Citrate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Tofacitinib Citrate Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tofacitinib Citrate Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Tofacitinib Citrate Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tofacitinib Citrate Tablets Market Facts & Figures by Country
3.7.1 Latin America Tofacitinib Citrate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tofacitinib Citrate Tablets Sales by Country (2020-2031)
3.7.3 Latin America Tofacitinib Citrate Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tofacitinib Citrate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Tofacitinib Citrate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tofacitinib Citrate Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tofacitinib Citrate Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tofacitinib Citrate Tablets Sales by Type (2020-2031)
4.1.1 Global Tofacitinib Citrate Tablets Sales by Type (2020-2025)
4.1.2 Global Tofacitinib Citrate Tablets Sales by Type (2026-2031)
4.1.3 Global Tofacitinib Citrate Tablets Sales Market Share by Type (2020-2031)
4.2 Global Tofacitinib Citrate Tablets Revenue by Type (2020-2031)
4.2.1 Global Tofacitinib Citrate Tablets Revenue by Type (2020-2025)
4.2.2 Global Tofacitinib Citrate Tablets Revenue by Type (2026-2031)
4.2.3 Global Tofacitinib Citrate Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Tofacitinib Citrate Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tofacitinib Citrate Tablets Sales by Application (2020-2031)
5.1.1 Global Tofacitinib Citrate Tablets Sales by Application (2020-2025)
5.1.2 Global Tofacitinib Citrate Tablets Sales by Application (2026-2031)
5.1.3 Global Tofacitinib Citrate Tablets Sales Market Share by Application (2020-2031)
5.2 Global Tofacitinib Citrate Tablets Revenue by Application (2020-2031)
5.2.1 Global Tofacitinib Citrate Tablets Revenue by Application (2020-2025)
5.2.2 Global Tofacitinib Citrate Tablets Revenue by Application (2026-2031)
5.2.3 Global Tofacitinib Citrate Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Tofacitinib Citrate Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Tofacitinib Citrate Tablets Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Zhejiang Hisun Pharmaceutical Co., Ltd.
6.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
6.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
6.3.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
6.3.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.3.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Hunan Jiudian Pharmaceutical Co., Ltd.
6.4.1 Hunan Jiudian Pharmaceutical Co., Ltd. Company Information
6.4.2 Hunan Jiudian Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.4.5 Hunan Jiudian Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 CSPC OUYI Pharmaceutical Co., Ltd.
6.5.1 CSPC OUYI Pharmaceutical Co., Ltd. Company Information
6.5.2 CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.5.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Chengdu Brilliant Pharmaceutical Co., Ltd.
6.6.1 Chengdu Brilliant Pharmaceutical Co., Ltd. Company Information
6.6.2 Chengdu Brilliant Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.6.5 Chengdu Brilliant Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Simcere Pharmaceutical Group Limited
6.7.1 Simcere Pharmaceutical Group Limited Company Information
6.7.2 Simcere Pharmaceutical Group Limited Description and Business Overview
6.7.3 Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Product Portfolio
6.7.5 Simcere Pharmaceutical Group Limited Recent Developments/Updates
6.8 Sinomune Pharmaceutical Co., Ltd.
6.8.1 Sinomune Pharmaceutical Co., Ltd. Company Information
6.8.2 Sinomune Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.8.5 Sinomune Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 QILU Pharmaceutical Co., Ltd.
6.9.1 QILU Pharmaceutical Co., Ltd. Company Information
6.9.2 QILU Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.9.5 QILU Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Hangzhou zuyaxi MedicineCo.,Ltd.
6.10.1 Hangzhou zuyaxi MedicineCo.,Ltd. Company Information
6.10.2 Hangzhou zuyaxi MedicineCo.,Ltd. Description and Business Overview
6.10.3 Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.10.5 Hangzhou zuyaxi MedicineCo.,Ltd. Recent Developments/Updates
6.11 SPH Zhongxi Pharmaceutical Co., Ltd.
6.11.1 SPH Zhongxi Pharmaceutical Co., Ltd. Company Information
6.11.2 SPH Zhongxi Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.11.5 SPH Zhongxi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Hunan Kelun Pharmaceutical Co., Ltd.
6.12.1 Hunan Kelun Pharmaceutical Co., Ltd. Company Information
6.12.2 Hunan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product Portfolio
6.12.5 Hunan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tofacitinib Citrate Tablets Industry Chain Analysis
7.2 Tofacitinib Citrate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tofacitinib Citrate Tablets Production Mode & Process Analysis
7.4 Tofacitinib Citrate Tablets Sales and Marketing
7.4.1 Tofacitinib Citrate Tablets Sales Channels
7.4.2 Tofacitinib Citrate Tablets Distributors
7.5 Tofacitinib Citrate Tablets Customer Analysis
8 Tofacitinib Citrate Tablets Market Dynamics
8.1 Tofacitinib Citrate Tablets Industry Trends
8.2 Tofacitinib Citrate Tablets Market Drivers
8.3 Tofacitinib Citrate Tablets Market Challenges
8.4 Tofacitinib Citrate Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Simcere Pharmaceutical Group Limited
Qilu Pharmaceutical Co. Ltd.
SPH Zhongxi Pharmaceutical Co., Ltd.
Hunan Kelun Pharmaceutical Co., Ltd.
Sinomune Pharmaceutical Co., Ltd.
Hangzhou zuyaxi MedicineCo.,Ltd.
Zhejiang Hisun Pharmaceutical Co Ltd
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Pfizer Inc
Hunan Jiudian Pharmaceutical Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.
List of Tables
 Table 1. Global Tofacitinib Citrate Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tofacitinib Citrate Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tofacitinib Citrate Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tofacitinib Citrate Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tofacitinib Citrate Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tofacitinib Citrate Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tofacitinib Citrate Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tofacitinib Citrate Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tofacitinib Citrate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tofacitinib Citrate Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tofacitinib Citrate Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Tofacitinib Citrate Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tofacitinib Citrate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tofacitinib Citrate Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tofacitinib Citrate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tofacitinib Citrate Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tofacitinib Citrate Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Tofacitinib Citrate Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tofacitinib Citrate Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Tofacitinib Citrate Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tofacitinib Citrate Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Tofacitinib Citrate Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tofacitinib Citrate Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Tofacitinib Citrate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tofacitinib Citrate Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tofacitinib Citrate Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tofacitinib Citrate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tofacitinib Citrate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tofacitinib Citrate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tofacitinib Citrate Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tofacitinib Citrate Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tofacitinib Citrate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tofacitinib Citrate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tofacitinib Citrate Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tofacitinib Citrate Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tofacitinib Citrate Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tofacitinib Citrate Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tofacitinib Citrate Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tofacitinib Citrate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tofacitinib Citrate Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tofacitinib Citrate Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tofacitinib Citrate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tofacitinib Citrate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tofacitinib Citrate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tofacitinib Citrate Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tofacitinib Citrate Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tofacitinib Citrate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tofacitinib Citrate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tofacitinib Citrate Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Tofacitinib Citrate Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Tofacitinib Citrate Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Tofacitinib Citrate Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Tofacitinib Citrate Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tofacitinib Citrate Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tofacitinib Citrate Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Tofacitinib Citrate Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Tofacitinib Citrate Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tofacitinib Citrate Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tofacitinib Citrate Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Tofacitinib Citrate Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Tofacitinib Citrate Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Tofacitinib Citrate Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Tofacitinib Citrate Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tofacitinib Citrate Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tofacitinib Citrate Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Tofacitinib Citrate Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Tofacitinib Citrate Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tofacitinib Citrate Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Tofacitinib Citrate Tablets Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
 Table 76. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 79. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
 Table 81. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 84. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Hunan Jiudian Pharmaceutical Co., Ltd. Company Information
 Table 86. Hunan Jiudian Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 89. Hunan Jiudian Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. CSPC OUYI Pharmaceutical Co., Ltd. Company Information
 Table 91. CSPC OUYI Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 94. CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Chengdu Brilliant Pharmaceutical Co., Ltd. Company Information
 Table 96. Chengdu Brilliant Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 99. Chengdu Brilliant Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Simcere Pharmaceutical Group Limited Company Information
 Table 101. Simcere Pharmaceutical Group Limited Description and Business Overview
 Table 102. Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Product
 Table 104. Simcere Pharmaceutical Group Limited Recent Developments/Updates
 Table 105. Sinomune Pharmaceutical Co., Ltd. Company Information
 Table 106. Sinomune Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 109. Sinomune Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. QILU Pharmaceutical Co., Ltd. Company Information
 Table 111. QILU Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 114. QILU Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Hangzhou zuyaxi MedicineCo.,Ltd. Company Information
 Table 116. Hangzhou zuyaxi MedicineCo.,Ltd. Description and Business Overview
 Table 117. Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Product
 Table 119. Hangzhou zuyaxi MedicineCo.,Ltd. Recent Developments/Updates
 Table 120. SPH Zhongxi Pharmaceutical Co., Ltd. Company Information
 Table 121. SPH Zhongxi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 122. SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 124. SPH Zhongxi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Hunan Kelun Pharmaceutical Co., Ltd. Company Information
 Table 126. Hunan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
 Table 129. Hunan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Tofacitinib Citrate Tablets Distributors List
 Table 133. Tofacitinib Citrate Tablets Customers List
 Table 134. Tofacitinib Citrate Tablets Market Trends
 Table 135. Tofacitinib Citrate Tablets Market Drivers
 Table 136. Tofacitinib Citrate Tablets Market Challenges
 Table 137. Tofacitinib Citrate Tablets Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tofacitinib Citrate Tablets
 Figure 2. Global Tofacitinib Citrate Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tofacitinib Citrate Tablets Market Share by Type: 2024 & 2031
 Figure 4. 14 tablets/bottle Product Picture
 Figure 5. 28 tablets/bottle Product Picture
 Figure 6. Other Specifications Product Picture
 Figure 7. Global Tofacitinib Citrate Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Tofacitinib Citrate Tablets Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Retail Pharmacy
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Global Tofacitinib Citrate Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Tofacitinib Citrate Tablets Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Tofacitinib Citrate Tablets Sales (2020-2031) & (K Units)
 Figure 16. Global Tofacitinib Citrate Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 17. Tofacitinib Citrate Tablets Report Years Considered
 Figure 18. Tofacitinib Citrate Tablets Sales Share by Manufacturers in 2024
 Figure 19. Global Tofacitinib Citrate Tablets Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Tofacitinib Citrate Tablets Players: Market Share by Revenue in Tofacitinib Citrate Tablets in 2024
 Figure 21. Tofacitinib Citrate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Tofacitinib Citrate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Tofacitinib Citrate Tablets Sales Market Share by Country (2020-2031)
 Figure 24. North America Tofacitinib Citrate Tablets Revenue Market Share by Country (2020-2031)
 Figure 25. United States Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Tofacitinib Citrate Tablets Sales Market Share by Country (2020-2031)
 Figure 28. Europe Tofacitinib Citrate Tablets Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Tofacitinib Citrate Tablets Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Tofacitinib Citrate Tablets Revenue Market Share by Region (2020-2031)
 Figure 36. China Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Tofacitinib Citrate Tablets Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Tofacitinib Citrate Tablets Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Tofacitinib Citrate Tablets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Tofacitinib Citrate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Tofacitinib Citrate Tablets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Tofacitinib Citrate Tablets by Type (2020-2031)
 Figure 55. Global Tofacitinib Citrate Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Tofacitinib Citrate Tablets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Tofacitinib Citrate Tablets by Application (2020-2031)
 Figure 58. Global Tofacitinib Citrate Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 59. Tofacitinib Citrate Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Tofacitinib Citrate Extended Release Tablets Market Research Report 2024
Global Tofacitinib Citrate Market Research Report 2025
Global Tofacitinib Citrate API Market Research Report 2025
Global Tofacitinib Market Research Report 2024
Global Tamoxifen Citrate Tablets Market Research Report 2024
Global Sorafenib Tosylate Tablets Market Research Report 2024
Global Tofacitinib Tablets Market Research Report 2024
Global Calcium Citrate Tablets Market Research Report 2025
Global Generic Tofacitinib Market Research Report 2025
Global Tamoxifen Citrate Drugs Market Research Report 2024
Global Filgotinib Tablets Market Research Report 2024
Global Tamoxifen Citrate API Market Research Report 2025
Global Baricitinib Market Research Report 2024
Global Maropitant Citrate Tablets Market Research Report 2024
Global Sorafenib Tablet Market Research Report 2024
Tricalcium Citrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Xeljanz tofacitnib Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tolterodine Tartrate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Axitinib Tablets Market Research Report 2024
Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions